MAC-话题@MedSci

#MAC#

655篇内容 | 2721人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1996347, encodeId=07fa199634e1c, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biochem Pharmacol：前列腺癌中代谢稳定的二苯胺衍生物能够抑制雄激素受体和BET蛋白 , objectType=article, longId=192053, objectId=aa691920531f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa691920531f, replyNumber=0, likeNumber=63, createdTime=2020-08-01, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa691920531f, moduleTitle=Biochem Pharmacol：前列腺癌中代谢稳定的二苯胺衍生物能够抑制雄激素受体和BET蛋白 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa691920531f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996318, encodeId=d94719963189d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=2019 ESMO|内分泌治疗是激素受体阳性乳腺癌重要的治疗手段，Abemaciclib显著延长HR+/HER2-mBC患者PFS, objectType=article, longId=181298, objectId=eae9181298b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eae9181298b0, replyNumber=0, likeNumber=67, createdTime=2020-06-30, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eae9181298b0, moduleTitle=2019 ESMO|内分泌治疗是激素受体阳性乳腺癌重要的治疗手段，Abemaciclib显著延长HR+/HER2-mBC患者PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eae9181298b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996316, encodeId=08f01996316b7, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Macromol Biosci：BCPx/PMMA骨水泥可有效恢复骨缺损, objectType=article, longId=180490, objectId=78ff18049087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78ff18049087, replyNumber=0, likeNumber=54, createdTime=2020-07-30, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78ff18049087, moduleTitle=Macromol Biosci：BCPx/PMMA骨水泥可有效恢复骨缺损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78ff18049087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996368, encodeId=9fcf199636862, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Inflammopharmacology：牙周非手术治疗后辅助使用褪黑素可改善CP患者的T2DM的炎症和牙周状态, objectType=article, longId=199335, objectId=3e6419933561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e6419933561, replyNumber=0, likeNumber=102, createdTime=2020-08-29, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e6419933561, moduleTitle=Inflammopharmacology：牙周非手术治疗后辅助使用褪黑素可改善CP患者的T2DM的炎症和牙周状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e6419933561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996346, encodeId=f9c7199634632, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Alimentary Pharmacology Therapeutics：幽门螺杆菌感染可降低食道和近端胃的腺癌发生率 , objectType=article, longId=191616, objectId=54c019161677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54c019161677, replyNumber=0, likeNumber=92, createdTime=2021-02-13, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54c019161677, moduleTitle=Alimentary Pharmacology Therapeutics：幽门螺杆菌感染可降低食道和近端胃的腺癌发生率 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54c019161677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996364, encodeId=29e219963647a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int Immunopharmacol：MicroRNA-345-5p是实验过敏性鼻炎中的一个抗炎症因子 , objectType=article, longId=197665, objectId=997619e66516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=997619e66516, replyNumber=0, likeNumber=54, createdTime=2021-02-15, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=997619e66516, moduleTitle=Int Immunopharmacol：MicroRNA-345-5p是实验过敏性鼻炎中的一个抗炎症因子 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=997619e66516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996341, encodeId=c6ab19963415c, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Clin Pharmacol Ther：富马酸酮替芬和布地奈德联用喷雾治疗过敏性鼻炎研究 , objectType=article, longId=190255, objectId=dc5119025548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc5119025548, replyNumber=0, likeNumber=66, createdTime=2020-12-29, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc5119025548, moduleTitle=Int J Clin Pharmacol Ther：富马酸酮替芬和布地奈德联用喷雾治疗过敏性鼻炎研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc5119025548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996322, encodeId=4c9d199632247, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=胡夕春教授：MONARCH plus研究——Abemaciclib给中国HR+/HER2-晚期乳腺癌患者带来新的希望, objectType=article, longId=181756, objectId=a252181e564c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a252181e564c, replyNumber=0, likeNumber=62, createdTime=2020-03-22, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a252181e564c, moduleTitle=胡夕春教授：MONARCH plus研究——Abemaciclib给中国HR+/HER2-晚期乳腺癌患者带来新的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a252181e564c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定, objectType=article, longId=179480, objectId=a6c61e94804e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6c61e94804e, replyNumber=0, likeNumber=145, createdTime=2020-04-08, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6c61e94804e, moduleTitle=美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6c61e94804e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996319, encodeId=d3eb1996319ff, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Biol Macromol：基因修饰的CS/nHAp/nZrO2支架或可用于临床骨缺损的修复, objectType=article, longId=181306, objectId=6e7b181306ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e7b181306ea, replyNumber=0, likeNumber=66, createdTime=2020-01-28, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e7b181306ea, moduleTitle=Int J Biol Macromol：基因修饰的CS/nHAp/nZrO2支架或可用于临床骨缺损的修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e7b181306ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996336, encodeId=a5e7199633647, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染, objectType=article, longId=188697, objectId=625518869e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625518869e6a, replyNumber=0, likeNumber=63, createdTime=2021-01-14, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625518869e6a, moduleTitle=Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625518869e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996307, encodeId=11cc199630e20, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败, objectType=article, longId=177158, objectId=67421e715857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67421e715857, replyNumber=0, likeNumber=60, createdTime=2019-10-22, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67421e715857, moduleTitle=Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67421e715857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996356, encodeId=35841996356d2, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Acta Pharmaceutica Sinica B：上海药物所开发抗新冠肺炎药物靶标预测及虚拟筛选网络应用平台, objectType=article, longId=193917, objectId=af9919391eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9919391eba, replyNumber=0, likeNumber=80, createdTime=2020-11-01, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9919391eba, moduleTitle=Acta Pharmaceutica Sinica B：上海药物所开发抗新冠肺炎药物靶标预测及虚拟筛选网络应用平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9919391eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996304, encodeId=24b91996304b9, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, objectType=article, longId=176305, objectId=2c551e63051c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c551e63051c, replyNumber=0, likeNumber=73, createdTime=2019-11-18, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c551e63051c, moduleTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c551e63051c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996325, encodeId=9f1e199632539, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Biol Macromol：骨状氧化锆纳米陶瓷改性壳聚糖基多孔纳米复合材料可用作骨组织工程, objectType=article, longId=183764, objectId=f9cc183e64e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9cc183e64e0, replyNumber=0, likeNumber=112, createdTime=2020-07-08, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9cc183e64e0, moduleTitle=Int J Biol Macromol：骨状氧化锆纳米陶瓷改性壳聚糖基多孔纳米复合材料可用作骨组织工程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9cc183e64e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996315, encodeId=d15b19963156f, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, objectType=article, longId=179627, objectId=a28c1e962734, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a28c1e962734, replyNumber=0, likeNumber=58, createdTime=2020-05-17, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a28c1e962734, moduleTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a28c1e962734)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996309, encodeId=81011996309f7, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生, objectType=article, longId=177308, objectId=61c21e7308ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c21e7308ae, replyNumber=0, likeNumber=50, createdTime=2019-11-09, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c21e7308ae, moduleTitle=Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c21e7308ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996311, encodeId=445b1996311cc, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死, objectType=article, longId=177350, objectId=81311e7350b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81311e7350b0, replyNumber=0, likeNumber=62, createdTime=2020-07-12, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81311e7350b0, moduleTitle=Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81311e7350b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996354, encodeId=e2da199635411, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, objectType=article, longId=193428, objectId=0ecb1934282c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ecb1934282c, replyNumber=0, likeNumber=54, createdTime=2021-03-02, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ecb1934282c, moduleTitle=J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ecb1934282c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996352, encodeId=f42e19963522d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmaceutics：西地那非体外溶解动力学揭示以用于新制剂的开发, objectType=article, longId=192979, objectId=da761929e91a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da761929e91a, replyNumber=0, likeNumber=60, createdTime=2020-07-15, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da761929e91a, moduleTitle=Pharmaceutics：西地那非体外溶解动力学揭示以用于新制剂的开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da761929e91a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MAC

2020-05-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biochem Pharmacol：前列腺癌中代谢稳定的二苯胺衍生物能够抑制雄激素受体和BET蛋白

2020-08-01

yb6560 (审核中...)

前往app查看评论内容

#MAC#

2019 ESMO|内分泌治疗是激素受体阳性乳腺癌重要的治疗手段，Abemaciclib显著延长HR+/HER2-mBC患者PFS

2020-06-30

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Macromol Biosci：BCPx/PMMA骨水泥可有效恢复骨缺损

2020-07-30

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Inflammopharmacology：牙周非手术治疗后辅助使用褪黑素可改善CP患者的T2DM的炎症和牙周状态

2020-08-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Alimentary Pharmacology Therapeutics：幽门螺杆菌感染可降低食道和近端胃的腺癌发生率

2021-02-13

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int Immunopharmacol：MicroRNA-345-5p是实验过敏性鼻炎中的一个抗炎症因子

2021-02-15

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Clin Pharmacol Ther：富马酸酮替芬和布地奈德联用喷雾治疗过敏性鼻炎研究

2020-12-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

胡夕春教授：MONARCH plus研究——Abemaciclib给中国HR+/HER2-晚期乳腺癌患者带来新的希望

2020-03-22

yb6560 (审核中...)

前往app查看评论内容

#MAC#

美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定

2020-04-08

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Biol Macromol：基因修饰的CS/nHAp/nZrO2支架或可用于临床骨缺损的修复

2020-01-28

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染

2021-01-14

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败

2019-10-22

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Acta Pharmaceutica Sinica B：上海药物所开发抗新冠肺炎药物靶标预测及虚拟筛选网络应用平台

2020-11-01

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症

2019-11-18

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Biol Macromol：骨状氧化锆纳米陶瓷改性壳聚糖基多孔纳米复合材料可用作骨组织工程

2020-07-08

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利

2020-05-17

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生

2019-11-09

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死

2020-07-12

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究

2021-03-02

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmaceutics：西地那非体外溶解动力学揭示以用于新制剂的开发

2020-07-15

科室
- - 订阅+
  - 更多科室
工具
服务